A detailed history of Winton Group LTD transactions in Vericel Corp stock. As of the latest transaction made, Winton Group LTD holds 21,985 shares of VCEL stock, worth $987,346. This represents 0.08% of its overall portfolio holdings.

Number of Shares
21,985
Previous 13,464 63.29%
Holding current value
$987,346
Previous $479,000 138.62%
% of portfolio
0.08%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $277,102 - $445,903
8,521 Added 63.29%
21,985 $1.14 Million
Q4 2023

Feb 12, 2024

BUY
$30.85 - $37.09 $555 - $667
18 Added 0.13%
13,464 $479,000
Q3 2023

Nov 13, 2023

BUY
$31.69 - $39.25 $252,854 - $313,175
7,979 Added 145.95%
13,446 $450,000
Q2 2023

Aug 14, 2023

BUY
$29.0 - $38.37 $158,543 - $209,768
5,467 New
5,467 $205,000
Q4 2021

Feb 10, 2022

SELL
$35.2 - $52.6 $776,582 - $1.16 Million
-22,062 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$46.35 - $59.75 $297,103 - $382,997
-6,410 Reduced 22.51%
22,062 $1.08 Million
Q2 2021

Aug 10, 2021

SELL
$47.2 - $67.81 $422,912 - $607,577
-8,960 Reduced 23.94%
28,472 $1.5 Million
Q1 2021

Jul 21, 2021

SELL
$30.93 - $59.48 $147,783 - $284,195
-4,778 Reduced 11.32%
37,432 $2.08 Million
Q4 2020

Feb 12, 2021

SELL
$18.53 - $31.5 $1.31 Million - $2.23 Million
-70,831 Reduced 62.66%
42,210 $1.3 Million
Q3 2020

Oct 30, 2020

SELL
$14.68 - $19.12 $53,890 - $70,189
-3,671 Reduced 3.15%
113,041 $2.1 Million
Q2 2020

Aug 05, 2020

BUY
$8.5 - $15.82 $470,305 - $875,320
55,330 Added 90.14%
116,712 $1.61 Million
Q1 2020

May 11, 2020

BUY
$7.25 - $19.22 $10,179 - $26,984
1,404 Added 2.34%
61,382 $563,000
Q4 2019

Feb 13, 2020

BUY
$13.77 - $19.2 $825,897 - $1.15 Million
59,978 New
59,978 $1.04 Million
Q3 2019

Nov 08, 2019

SELL
$14.93 - $19.83 $163,140 - $216,682
-10,927 Closed
0 $0
Q2 2019

Jul 08, 2019

SELL
$15.01 - $18.89 $85,872 - $108,069
-5,721 Reduced 34.36%
10,927 $206,000
Q1 2019

May 13, 2019

BUY
$16.23 - $20.29 $270,197 - $337,787
16,648 New
16,648 $292,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.12B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.